These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29681898)

  • 21. Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains.
    Varga JJ; Barbier M; Mulet X; Bielecki P; Bartell JA; Owings JP; Martinez-Ramos I; Hittle LE; Davis MR; Damron FH; Liechti GW; Puchałka J; dos Santos VA; Ernst RK; Papin JA; Albertí S; Oliver A; Goldberg JB
    BMC Genomics; 2015 Oct; 16():883. PubMed ID: 26519161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
    Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
    Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and antibiotic resistance trends in clinical isolates of Pseudomonas aeruginosa from Rio de janeiro - Brazil: Importance of mutational mechanisms over the years (1995-2015).
    de Oliveira Santos IC; Pereira de Andrade NF; da Conceição Neto OC; da Costa BS; de Andrade Marques E; Rocha-de-Souza CM; Asensi MD; D'Alincourt Carvalho-Assef AP
    Infect Genet Evol; 2019 Sep; 73():411-415. PubMed ID: 31121306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance of Pseudomonas species.
    Prince A
    J Pediatr; 1986 May; 108(5 Pt 2):830-4. PubMed ID: 3701534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam.
    Sanz-García F; Hernando-Amado S; Martínez JL
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative genomics of a drug-resistant Pseudomonas aeruginosa panel and the challenges of antimicrobial resistance prediction from genomes.
    Jeukens J; Kukavica-Ibrulj I; Emond-Rheault JG; Freschi L; Levesque RC
    FEMS Microbiol Lett; 2017 Oct; 364(18):. PubMed ID: 28922838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone.
    Arca-Suárez J; Fraile-Ribot P; Vázquez-Ucha JC; Cabot G; Martínez-Guitián M; Lence E; González-Bello C; Beceiro A; Rodríguez-Iglesias M; Galán-Sánchez F; Bou G; Oliver A
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous Antimicrobial Susceptibility Characteristics in
    Qin X; Zhou C; Zerr DM; Adler A; Addetia A; Yuan S; Greninger AL
    mSphere; 2018; 3(2):. PubMed ID: 29564400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persistence and Microevolution of
    Bianconi I; D'Arcangelo S; Esposito A; Benedet M; Piffer E; Dinnella G; Gualdi P; Schinella M; Baldo E; Donati C; Jousson O
    Front Microbiol; 2018; 9():3242. PubMed ID: 30692969
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic and metal resistance in a ST395 Pseudomonas aeruginosa environmental isolate: A genomics approach.
    Teixeira P; Tacão M; Alves A; Henriques I
    Mar Pollut Bull; 2016 Sep; 110(1):75-81. PubMed ID: 27371958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic characterization of multidrug-resistant ESBL-producing Klebsiella pneumoniae isolated from a Ghanaian teaching hospital.
    Agyepong N; Govinden U; Owusu-Ofori A; Amoako DG; Allam M; Janice J; Pedersen T; Sundsfjord A; Essack S
    Int J Infect Dis; 2019 Aug; 85():117-123. PubMed ID: 31129424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
    Millar BC; McCaughan J; Rendall JC; Downey DG; Moore JE
    J Clin Pharm Ther; 2018 Feb; 43(1):92-100. PubMed ID: 29293275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution.
    Botelho J; Grosso F; Peixe L
    Drug Resist Updat; 2019 May; 44():100640. PubMed ID: 31492517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolone Prophylaxis Selects for Meropenem-nonsusceptible Pseudomonas aeruginosa in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients.
    Hakki M; Humphries RM; Hemarajata P; Tallman GB; Shields RK; Mettus RT; Doi Y; Lewis JS
    Clin Infect Dis; 2019 May; 68(12):2045-2052. PubMed ID: 30256922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa.
    Khaledi A; Schniederjans M; Pohl S; Rainer R; Bodenhofer U; Xia B; Klawonn F; Bruchmann S; Preusse M; Eckweiler D; Dötsch A; Häussler S
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4722-33. PubMed ID: 27216077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
    Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The evolution of antimicrobial peptide resistance in Pseudomonas aeruginosa is shaped by strong epistatic interactions.
    Jochumsen N; Marvig RL; Damkiær S; Jensen RL; Paulander W; Molin S; Jelsbak L; Folkesson A
    Nat Commun; 2016 Oct; 7():13002. PubMed ID: 27694971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.